GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

Начало・Списък с акции・Vivesto AB

Vivesto AB

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Приходи	-1.9M -9.1M
EPS	-0.015
Служители	4
EBITDA	-1.8M -8.9M

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-1.9M 49M
Предишно отваряне	0
Предишно затваряне	0

Vivesto AB Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.03.2026 г., 21:37 ч. UTC

Придобивния, сливания и поглъщания

Lensar and Alcon Agree to Terminate Merger

16.03.2026 г., 19:06 ч. UTC

Значими събития в новините

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16.03.2026 г., 17:44 ч. UTC

Придобивния, сливания и поглъщания

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16.03.2026 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

16.03.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise After Oil Prices Decline -- Market Talk

16.03.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16.03.2026 г., 23:05 ч. UTC

Пазарно говорене

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16.03.2026 г., 21:56 ч. UTC

Пазарно говорене

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16.03.2026 г., 21:41 ч. UTC

Пазарно говорене

Значими събития в новините

Global Equities Roundup: Market Talk

16.03.2026 г., 21:41 ч. UTC

Пазарно говорене

Значими събития в новините

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16.03.2026 г., 20:59 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16.03.2026 г., 20:59 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16.03.2026 г., 20:59 ч. UTC

Придобивния, сливания и поглъщания

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16.03.2026 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16.03.2026 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

16.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Energy & Utilities Roundup: Market Talk

16.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

16.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

16.03.2026 г., 19:53 ч. UTC

Значими събития в новините

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16.03.2026 г., 19:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

16.03.2026 г., 19:43 ч. UTC

Пазарно говорене

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16.03.2026 г., 19:37 ч. UTC

Пазарно говорене

Значими събития в новините

Natural Gas Follows Oil Prices Lower -- Market Talk

16.03.2026 г., 19:20 ч. UTC

Значими събития в новините

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16.03.2026 г., 19:17 ч. UTC

Пазарно говорене

Значими събития в новините

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16.03.2026 г., 19:00 ч. UTC

Пазарно говорене

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16.03.2026 г., 18:23 ч. UTC

Пазарно говорене

LME Restarts Trading After Outage -- Market Talk

16.03.2026 г., 17:36 ч. UTC

Значими събития в новините

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16.03.2026 г., 17:19 ч. UTC

Пазарно говорене

Grains Sink as Investors Steer Toward Equities -- Market Talk

16.03.2026 г., 17:14 ч. UTC

Значими събития в новините

Trump Ends News Conference

Сравнение с други в отрасъла

Ценова промяна

Vivesto AB Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.